Poly I: C-Activated Dendritic Cells That Were Generated in CellGro for Use in Cancer Immunotherapy Trials

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-9-223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

iPS Cells Reprogrammed From Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2019English

Dendritic Cell-Based Immunotherapy for Prostate Cancer

CA - A Cancer Journal for Clinicians
OncologyHematology
1999English

Effect of Microsphere-Encapsulated Antigen in Maturation of CD103+ Dendritic Cells for Use in Allergen-Specific Immunotherapy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Induction of Multi-Functional T Cells in a Phase I Clinical Trial of Dendritic Cell Immunotherapy in Hepatitis C Virus Infected Individuals

PLoS ONE
Multidisciplinary
2012English

Immunotherapy and Potential Use of Propolis in Cancer Immunotherapy

Food and Health
2018English

Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy

Journal of Immunology
AllergyImmunology
2001English

Activated Protein C Targets CD8+ Dendritic Cells to Reduce the Mortality of Endotoxemia in Mice

Journal of Clinical Investigation
Medicine
2010English

Regulatory T Cells in Cancer Immunotherapy

Current Opinion in Immunology
AllergyImmunology
2014English

Regulatory T Cells in Cancer Immunotherapy

Cell Research
Cell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy